| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.3M | +2.1% | -6.7% |
| R&D Expense | $10.3M | -31.3% | -53.4% |
| SG&A Expense | $6.7M | -64.7% | -41.1% |
| Operating Income | -$15.7M | +51.4% | +52.5% |
| Income Tax | $0 | — | — |
| Net Income | $2.9M | +108.8% | +105.0% |
| EPS (Basic) | $1.14 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $19.6M | -47.5% | -66.6% |
| Accounts Receivable | $8.7M | +22.9% | -40.5% |
| Current Assets | $50.6M | -23.5% | -62.9% |
| Total Assets | $99.3M | -14.6% | -54.1% |
| Current Liabilities | $24.8M | -55.5% | -47.1% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$58.7M | — | — |
| Capital Expenditures | $1.0M | — | — |
| Investing Cash Flow | $11.4M | — | — |
| Financing Cash Flow | $25.6M | — | — |
| Free Cash Flow | -$59.7M | — | — |
| +493.1% |
| EPS (Diluted) | $0.99 | +760.0% | +441.4% |
| $91.1M |
| -29.0% |
| -55.0% |
| Stockholders' Equity | -$5.0M | +80.2% | -136.6% |